Cargando…
Urinary markers for bladder cancer
Bladder cancer has the fifth highest incidence of all malignancies in the United States, with a propensity to recur, requiring lifelong surveillance after diagnosis. Urinary markers of disease have been of extreme interest in this field in an effort to simplify surveillance schedules and improve ear...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702217/ https://www.ncbi.nlm.nih.gov/pubmed/23864929 http://dx.doi.org/10.12703/P5-21 |
_version_ | 1782275769155715072 |
---|---|
author | Smith, Zachary L. Guzzo, Thomas J. |
author_facet | Smith, Zachary L. Guzzo, Thomas J. |
author_sort | Smith, Zachary L. |
collection | PubMed |
description | Bladder cancer has the fifth highest incidence of all malignancies in the United States, with a propensity to recur, requiring lifelong surveillance after diagnosis. Urinary markers of disease have been of extreme interest in this field in an effort to simplify surveillance schedules and improve early detection of tumors. Many markers have been described, but most remain investigational. However, some markers have undergone clinical trials and are approved for clinical use. In this review, urinary markers and their application for screening and surveillance of bladder cancer are discussed. |
format | Online Article Text |
id | pubmed-3702217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-37022172013-07-17 Urinary markers for bladder cancer Smith, Zachary L. Guzzo, Thomas J. F1000Prime Rep Review Article Bladder cancer has the fifth highest incidence of all malignancies in the United States, with a propensity to recur, requiring lifelong surveillance after diagnosis. Urinary markers of disease have been of extreme interest in this field in an effort to simplify surveillance schedules and improve early detection of tumors. Many markers have been described, but most remain investigational. However, some markers have undergone clinical trials and are approved for clinical use. In this review, urinary markers and their application for screening and surveillance of bladder cancer are discussed. Faculty of 1000 Ltd 2013-07-01 /pmc/articles/PMC3702217/ /pubmed/23864929 http://dx.doi.org/10.12703/P5-21 Text en © 2013 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Smith, Zachary L. Guzzo, Thomas J. Urinary markers for bladder cancer |
title | Urinary markers for bladder cancer |
title_full | Urinary markers for bladder cancer |
title_fullStr | Urinary markers for bladder cancer |
title_full_unstemmed | Urinary markers for bladder cancer |
title_short | Urinary markers for bladder cancer |
title_sort | urinary markers for bladder cancer |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702217/ https://www.ncbi.nlm.nih.gov/pubmed/23864929 http://dx.doi.org/10.12703/P5-21 |
work_keys_str_mv | AT smithzacharyl urinarymarkersforbladdercancer AT guzzothomasj urinarymarkersforbladdercancer |